Susanna Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Susanna Liu has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Mark Gerstein
Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA
4 shared publications - Charlotte M. Brannon
Computational Biology and Bioinformatics Program, Yale University, New Haven, USA
2 shared publications - Eric Ni
Computational Biology and Bioinformatics Program, Yale University, New Haven, USA
2 shared publications - Gamze Gürsoy
Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, CB3 0WA, UK
2 shared publications - Tianxiao Li
NEC Laboratories America
2 shared publications - Alfred Kibowen
Division of Molecular Psychiatry, Department of Psychiatry, Yale University School of Medicine, New Haven, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 24 April 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (5) , 1079-1094
Transcriptomic and phenotypic convergence of neurodevelopmental disorder risk genes in vitro and in vivo
Diverse risk genes have been identified for neurodevelopmental disorders (NDDs), but how these genes converge on similar biological pathways in neurons, and thus give rise to similar phenotypes, is unclear. Here we apply a pooled CRISPR approach to successfully target 23 NDD loss-of-function genes with roles in chromatin biology and examine convergent effects on gene expression across human induced pluripotent stem cell-derived neural progenitor cells, glutamatergic neurons and GABAergic neurons. Points of convergence vary between these cell types, with the greatest number of convergent genes and strongest convergent networks in mature glutamatergic neurons, where they broadly represent synaptic, epigenetic and, unexpectedly, mitochondrial pathways. The most convergent networks were observed between NDD genes with shared biological annotations, clinical associations and co-expression patterns in human post-mortem brain. Drugs that were predicted to reverse convergent transcriptomic signatures and/or arousal and sensory processing behaviors ameliorated behavioral phenotypes in zebrafish NDD gene mutants. These results suggest that convergent effects of NDD risk genes could provide clinically useful insights.
- 24 April 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (5) , 1079-1094
Top Cited PapersOpen AccessTranscriptomic and phenotypic convergence of neurodevelopmental disorder risk genes in vitro and in vivo
Diverse risk genes have been identified for neurodevelopmental disorders (NDDs), but how these genes converge on similar biological pathways in neurons, and thus give rise to similar phenotypes, is unclear. Here we apply a pooled CRISPR approach to successfully target 23 NDD loss-of-function genes with roles in chromatin biology and examine convergent effects on gene expression across human induced pluripotent stem cell-derived neural progenitor cells, glutamatergic neurons and GABAergic neurons. Points of convergence vary between these cell types, with the greatest number of convergent genes and strongest convergent networks in mature glutamatergic neurons, where they broadly represent synaptic, epigenetic and, unexpectedly, mitochondrial pathways. The most convergent networks were observed between NDD genes with shared biological annotations, clinical associations and co-expression patterns in human post-mortem brain. Drugs that were predicted to reverse convergent transcriptomic signatures and/or arousal and sensory processing behaviors ameliorated behavioral phenotypes in zebrafish NDD gene mutants. These results suggest that convergent effects of NDD risk genes could provide clinically useful insights.
- Open Access
chronODE : A framework to integrate time-series multi-omics data based on ordinary differential equations combined with machine learning
Most functional genomic studies are conducted in steady-state conditions, therefore providing a description of molecular processes at a particular moment of cell differentiation or organismal development. Longitudinal studies can offer a deeper understanding of the kinetics underlying epigenetic events and their contribution to defining cell-type-specific transcriptional programs. Here we develop chronODE , a mathematical framework based on ordinary differential equations that uniformly models the kinetics of temporal changes in gene expression and chromatin features. chronODE employs biologically interpretable parameters that capture tissue-specific kinetics of genes and regulatory elements. We further integrate this framework with a neural-network architecture that can link and predict changes across different data modalities by solving multivariate time-series regressions. Next, we apply this framework to investigate region-specific kinetics of epigenome rewiring in the developing mouse brain, and we demonstrate that changes in chromatin accessibility within regulatory elements can accurately predict changes in the expression of putative target genes over the same time period. Finally, by integrating single-cell ATAC-seq data generated during the same time course, we show that regulatory elements characterized by fast activation kinetics in bulk measurements are active in early-appearing cell types, such as radial glial and other neural progenitors, whereas elements characterized by slow activation kinetics are specific to more differentiated cell types that emerge at later stages of brain development.
Open AccesschronODE : A framework to integrate time-series multi-omics data based on ordinary differential equations combined with machine learning
Most functional genomic studies are conducted in steady-state conditions, therefore providing a description of molecular processes at a particular moment of cell differentiation or organismal development. Longitudinal studies can offer a deeper understanding of the kinetics underlying epigenetic events and their contribution to defining cell-type-specific transcriptional programs. Here we develop chronODE , a mathematical framework based on ordinary differential equations that uniformly models the kinetics of temporal changes in gene expression and chromatin features. chronODE employs biologically interpretable parameters that capture tissue-specific kinetics of genes and regulatory elements. We further integrate this framework with a neural-network architecture that can link and predict changes across different data modalities by solving multivariate time-series regressions. Next, we apply this framework to investigate region-specific kinetics of epigenome rewiring in the developing mouse brain, and we demonstrate that changes in chromatin accessibility within regulatory elements can accurately predict changes in the expression of putative target genes over the same time period. Finally, by integrating single-cell ATAC-seq data generated during the same time course, we show that regulatory elements characterized by fast activation kinetics in bulk measurements are active in early-appearing cell types, such as radial glial and other neural progenitors, whereas elements characterized by slow activation kinetics are specific to more differentiated cell types that emerge at later stages of brain development.
- 22 November 2021
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 23 (4) , 259
Author Correction: Functional genomics data: privacy risk assessment and technological mitigation
- 22 November 2021
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 23 (4) , 259
Author Correction: Functional genomics data: privacy risk assessment and technological mitigation
- 10 November 2021
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 23 (4) , 245-258
Functional genomics data: privacy risk assessment and technological mitigation
The generation of functional genomics data by next-generation sequencing has increased greatly in the past decade. Broad sharing of these data is essential for research advancement but poses notable privacy challenges, some of which are analogous to those that occur when sharing genetic variant data. However, there are also unique privacy challenges that arise from cryptic information leakage during the processing and summarization of functional genomics data from raw reads to derived quantities, such as gene expression values. Here, we review these challenges and present potential solutions for mitigating privacy risks while allowing broad data dissemination and analysis.
- 10 November 2021
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 23 (4) , 245-258
Functional genomics data: privacy risk assessment and technological mitigation
The generation of functional genomics data by next-generation sequencing has increased greatly in the past decade. Broad sharing of these data is essential for research advancement but poses notable privacy challenges, some of which are analogous to those that occur when sharing genetic variant data. However, there are also unique privacy challenges that arise from cryptic information leakage during the processing and summarization of functional genomics data from raw reads to derived quantities, such as gene expression values. Here, we review these challenges and present potential solutions for mitigating privacy risks while allowing broad data dissemination and analysis.